Community-acquired pneumonia (CAP) is a heterogeneous illness, which most emergency departments and inpatient clinicians face on a frequent basis. 1,2 The disease process of CAP is continually changing and thereby causing significant morbidity and mortality, especially in the elderly. Therefore, it is important to be up-to-date on therapies and care standards. 2 In this regard, the present article highlights the patient treatment journey and emerging antibiotic therapies for CAP.
CAP is an acute and severe infection of the lung parenchyma. It is a major cause of mortality in adults, elderly, and immunocompromised individuals worldwide. 3,7 Severe CAP which is defined by the presence of symptoms of respiratory failure/severe sepsis/septic shock is responsible for causing around 10% of hospitalizations and subsequent mortality. 8 Among the causative pathogens, Streptococcus pneumoniae is…
